The cancer drug developer, which counts Novo Nordisk among its shareholders, floated below its range, but issued a larger number of shares than expected.

Software developer PE International has received repeat investments from Siemens Venture Capital and GIMV, taking its overall funding to almost $24m.

Biopharmaceutical company AM-Pharma has raised $15.8m in a series E round that included IdInvest Partners and AbbVie, and has now secured some $70m in total.

Funding for the centre comes via the UK Research Partnership Investment Fund, Technology Strategy Board and Masdar.

The internet company has now made about $300m in total from share sales in publicly traded payment company Qiwi.

Scientists at the institute are inching closer to a commercialisation for anti-malarial drugs.

Convibo offers customers an opportunity to collect their shopping from refrigerated lockers.

Covagen is a spin-out of ETH Zurich.

The Merck Serono spin-off has now secured $43m over two rounds as it prepares to advance its lead product candidate, which is targeted at diabetes sufferers.